Myriad Genetics Stock Price - MYGN

17.74
0.12 (0.68%)
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Pro
Monthly Subscription
for only
$49.05
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
VAT not included
Company Name Stock Ticker Symbol Market Type
Myriad Genetics Inc MYGN NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
0.34 1.97% 17.62 16.66 17.78 16.69 17.28 16:35:30
Bid Price Ask Price Spread Spread % News
17.03 17.74 0.71 4.0% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
9,476 1,046,482 $ 17.24 $ 18,041,102 1,130,631 16.66 - 48.40
Last Trade Time Type Quantity Stock Price Currency
16:44:57 formt 100 $ 17.74 USD

Myriad Genetics Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 1.31B 74.55M $ 131.10M 0.05 -47.78 71.15M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Myriad Genetics News

Loading Messages....

Latest MYGN Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical MYGN Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week19.8520.1416.6618.24872,859-2.23-11.23%
1 Month28.1730.1316.6621.301,397,923-10.55-37.45%
3 Months25.9430.1316.6624.12876,395-8.32-32.07%
6 Months22.1935.2916.6625.29949,779-4.57-20.59%
1 Year30.9048.4016.6628.101,032,103-13.28-42.98%
3 Years19.2550.4416.6630.02929,139-1.63-8.47%
5 Years33.9050.4415.1529.33956,301-16.28-48.02%

Myriad Genetics Description

Myriad Genetics is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease or tailor treatment for already diagnosed patients. The firm produces myRisk, a 28-gene panel with the capability to identify the elevated risk of developing eight types of cancer. Other diagnostic products include BRACAnalysis CDx, GeneSight, Vectra DA, and Prolaris. The firm also offers biomarker discovery and companion diagnostic services to pharmaceutical and biotechnology companies.


Your Recent History
NASDAQ
MYGN
Myriad Gen..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.